• Karachi, Pakistan

Haleon Pakistan Limited - HALEON

Company Details

Sector PHARMACEUTICALS
Address
Auditor
Registrar
Website
Fiscal Year
Details

Description

Company Announcements

Date/Time Announcement
25/10/2024   16:20:06 (UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 5447.831
(UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 3202.524
EPS = 27.36
FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2024
DIVIDEND= 50% (i)
BOOK CLOSURE FROM 07/11/2024
BOOK CLOSURE TO 08/11/2024
22/08/2024   16:51:09 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,872.740
PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 3,209.018
EPS = 16.00
FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2024
25/04/2024   16:27:35 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,117.512
FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/12/2023
EPS = 5.55
PROFIT/LOSS AFTER TAXATION RS. IN MILLION 649.281
05/03/2024   15:34:15 BOOK CLOSURE TO 26/04/2024
BOOK CLOSURE FROM 19/04/2024
ANNUAL GENERAL MEETING WILL BE HELD ON 26/04/2024
EPS = 8.51
PROFIT/LOSS AFTER TAXATION RS. IN MILLION 995.586
PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,846.133
FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2023
23/10/2023   16:08:12 EPS = 5.36
PROFIT/LOSS AFTER TAXATION RS. IN MILLION 627.355
PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,243.835
FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2023
22/08/2023   15:49:02 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 313.064
FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2023
PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 726.176
EPS = 2.67
02/05/2023   12:29:27 EPS = 2.59
FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2023
PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 468.104
PROFIT/LOSS AFTER TAXATION RS. IN MILLION 303.139
15/03/2023   15:43:25 BOOK CLOSURE TO 27/04/2023
BOOK CLOSURE FROM 20/04/2023
ANNUAL GENERAL MEETING HELD ON 27/04/2023
EPS = 2.78
PROFIT/LOSS AFTER TAXATION RS. IN MILLION 325.411
PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 992.791
FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2022

Last 30 Days Performance